2022 FDA Brand Name Annual Review

The Brandsymbol Regulatory Division invites you to read our 2022 Brand Name Annual Review. Each year we prepare this free publication analyzing brand names approved by the United States Food and Drug Administration (FDA) in the previous year. 

This year’s publication includes a selection of 63 brand names approved by the FDA for new molecular entities, biologics, and vaccines. With publically available profile information, we use our SafeMark® Model Name Safety Tools to provide insights on naming strategies we find relevant. We hope this publication provides new insights on brand name safety guidelines, FDA approval trends, and the prevention of medication errors in healthcare practice.  

We invite you to please reach out to our team, info@brandsymbol.com, with any questions.